BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 23281097)

  • 21. Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure.
    Sugimori C; Mochizuki K; Qi Z; Sugimori N; Ishiyama K; Kondo Y; Yamazaki H; Takami A; Okumura H; Nakao S
    Br J Haematol; 2009 Oct; 147(1):102-12. PubMed ID: 19656154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
    Mevorach D
    Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.
    Meletis J; Terpos E
    Med Sci Monit; 2003 Jul; 9(7):RA161-72. PubMed ID: 12883466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxysmal nocturnal hemoglobinuria with deletion of chromosome 13q (q12q14): a case report and review of the literature.
    Kim H; Hur M; Moon HW; Park CM; Yun YM; Kim SY
    Ann Clin Lab Sci; 2012; 42(3):313-7. PubMed ID: 22964621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates
    Dulau-Florea A; Maric I; Calvo KR; Braylan RC
    Semin Hematol; 2019 Jan; 56(1):65-68. PubMed ID: 30573047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
    Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
    Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Paroxysmal nocturnal hemoglobinuria--consequences of a missing anchor].
    Korte W; Heijnen IA
    Ther Umsch; 2006 Jan; 63(1):71-7. PubMed ID: 16450736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications].
    Xu C; Zhang T; Zhao R
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):511-4. PubMed ID: 11721394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes.
    Hanaoka N; Nakakuma H; Horikawa K; Nagakura S; Tsuzuki Y; Shimanuki M; Kojima K; Yonemura Y; Kawaguchi T
    Br J Haematol; 2009 Sep; 146(5):538-45. PubMed ID: 19594748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxysmal nocturnal hemoglobinuria in children.
    van den Heuvel-Eibrink MM
    Paediatr Drugs; 2007; 9(1):11-6. PubMed ID: 17291133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of unsuspected PNH-type cells in flow cytometric immunophenotypic analysis of peripheral blood and bone marrow.
    Thomason RW; Papiez J; Lee RV; Szczarkowski W
    Am J Clin Pathol; 2004 Jul; 122(1):128-34. PubMed ID: 15272541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Richards SJ; Dickinson AJ; Cullen MJ; Griffin M; Munir T; McKinley C; Mitchell LD; Newton DJ; Arnold L; Hill A; Hillmen P
    Br J Haematol; 2020 Jun; 189(5):954-966. PubMed ID: 32103498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric analysis of erythrocytes in paroxysmal nocturnal hemoglobinuria reveals superiority of CD59 as a diagnostic marker compared to CD55.
    Tembhare P; Ramani M; Syed K; Gupta AD
    Indian J Pathol Microbiol; 2010; 53(4):699-703. PubMed ID: 21045396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
    Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
    Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of paroxysmal nocturnal hemoglobinuria-phenotype in patients with chronic lymphocytic leukemia and multiple myeloma.
    Varma S; Varma N; Reddy VV; Naseem S; Bose P; Malhotra P
    Indian J Pathol Microbiol; 2012; 55(2):206-10. PubMed ID: 22771645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.
    Alfinito F; Del Vecchio L; Rocco S; Boccuni P; Musto P; Rotoli B
    Leukemia; 1996 Aug; 10(8):1326-30. PubMed ID: 8709638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiparameter flow cytometry for the diagnosis and monitoring of small GPI-deficient cellular populations.
    Battiwalla M; Hepgur M; Pan D; McCarthy PL; Ahluwalia MS; Camacho SH; Starostik P; Wallace PK
    Cytometry B Clin Cytom; 2010 Sep; 78(5):348-56. PubMed ID: 20533383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology.
    Bessler M; Schaefer A; Keller P
    Transfus Med Rev; 2001 Oct; 15(4):255-67. PubMed ID: 11668433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of a FLAER-based WBC assay in the primary screening of PNH clones.
    Sutherland DR; Kuek N; Azcona-Olivera J; Anderson T; Acton E; Barth D; Keeney M
    Am J Clin Pathol; 2009 Oct; 132(4):564-72. PubMed ID: 19762534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.